Tergus CEO to Speak at 6th Dermatological Product Development Workshop
Come Learn About Quality by Design for Topical Formulation
(firmenpresse) - RESEARCH TRIANGLE PARK, NC -- (Marketwired) -- 05/19/15 -- (), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I - III cGMP clinical supply manufacturing, is excited to announce that CEO and co-founder Vijendra Nalamothu is speaking at the 6th Dermatological Product Development Workshop in London, UK. He is also acting as a member of the steering committee for the event.
The Association for Applied Human Pharmacology (AGAH) is hosting the workshop and is a scientific medical non-profit organization whose members work in the field of explorative drug development and human pharmacology. The organization is open for professionals who work in the field of translational medicine, i.e. bringing new medicinal products from the bench into clinical research. The workshop will be held at the Cumberland Hotel in London, June 23rd and 24th.
"We are honored to be able to participate at an event that specifically brings together those involved in dermatological development," said Vijendra Nalamothu, CEO and co-founder of Tergus. "This workshop will deliver insight and thought leadership, as well as a glimpse into the direction this industry is going in the upcoming year."
Tergus leads the industry in having a fully developed and deployed Quality-by-Design (QbD) protocol for topical pharmaceuticals. Vijendra himself has extensive hands-on laboratory and project management experience in all stages of product development, from product concept and prototype development to market introduction of dermatological products and novel drug delivery products in an FDA-regulated environment.
Vijendra will speak at the workshop on the 23rd at 9:00 a.m. His topic is: "A Quality by Design approach for topical formulation development: Utilization of Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) that are linked to the Critical Quality Attributes (CQAs) in order to develop a topical product."
(Read news about current activities of the AGAH .)
Tergus () is the market leader in full-service topical pharmaceutical research, development, testing and manufacturing. The company has been an industry leader in topical pharmaceuticals for 18 years and has a state-of-the-art laboratory facility at Research Triangle Park in Durham, North Carolina. The company has a long and stellar reputation for delivering quality and results for clients from formulation through manufacturing. The company''s motto is "Think Topical. Think Tergus."
The Association for Applied Human Pharmacology (AGAH) is a scientifically and medically oriented non-profit organization which focuses on work in the field of explorative drug development and human pharmacology. The organization is especially a forum for professionals who work in the field of translational medicine, i.e. bringing new medicinal products from the bench into clinical research.
Contact:
Leslie Proctor
Springboard5
(801) 208-1100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.05.2015 - 08:59 Uhr
Sprache: Deutsch
News-ID 1359903
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
RESEARCH TRIANGLE PARK, NC
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 150 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tergus CEO to Speak at 6th Dermatological Product Development Workshop
"
steht unter der journalistisch-redaktionellen Verantwortung von
Tergus (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
